pharma news today obesity drugs glp-1 october 2025 Chart: 1 in 8 Americans Now Use for Weight Loss Anti-Obesity Drug Market Outlook 2025–2032:

[Dileucine, Dihydroberberine, & GLP-1 Research: Chad Kerksick 2 of 2 (PricePlow 142)]

Learn If GLP-1 Is the Same as Ozempic and How It Can Support Your Weight Loss Journey in Las Vegas, NV and Beverly Hills, CA.

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access Shape Patient Choices as MEDVi Lists Compounded GLP-1 Programs Starting at $179 Newark, DE, Dec - 29 December

Semaglutide and tirzepatide for visceral fat and the thin-fat phenotype

Direct-to-consumer health and wellness company Ro launched an online GLP-1 supply tracker as an interactive tool to give patients real-time insights on GLP-1 drug shortages